Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/03/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Purchase | Common Stock | 83.9k | $23.96 | $2M | By Trust | 08/03/2023 |
06/23/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 20.5k | $0.00 | $0 | | 06/23/2022 |
06/23/2022 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 31.5k | $7.35 | $231.5k | | 06/23/2022 |
06/09/2022 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $4.85 | $65.1k | | 06/09/2022 |
12/21/2021 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $14.92 | $200.2k | | 12/21/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Common Stock | 503.2k | $38.00 | $19.1M | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Common Stock | 409.9k | $38.00 | $15.6M | By Ronald Renaud 2014 Irrevocable Family Trust | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Common Stock | 40.9k | $38.00 | $1.6M | By Ronald C. Renaud, Jr. Trust - 2007 | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 500k | $7.95 | $4M | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 525k | $7.66 | $4M | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stcok Option (right to buy) | 325k | $23.82 | $7.7M | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 1.1M | $7.39 | $7.9M | | 09/14/2021 |
09/14/2021 | Translate Bio, Inc. | TBIO | Sale | Stock Option (right to buy) | 90k | $8.34 | $750.6k | | 09/14/2021 |
06/08/2021 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 17.5k | $13.80 | $241.5k | | 06/08/2021 |
06/08/2021 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 11k | $0.00 | $0 | | 06/08/2021 |
04/07/2021 | Translate Bio, Inc. | TBIO | Exercise | Stock Option (right to buy) | 9k | $7.39 | $66.7k | | 04/07/2021 |
04/07/2021 | Translate Bio, Inc. | TBIO | Exercise | Stock Option (right to buy) | 9k | $7.39 | $66.7k | | 04/07/2021 |
03/09/2021 | Translate Bio, Inc. | TBIO | Grant | Stock Option (right to buy) | 325k | $23.82 | $7.7M | | 03/09/2021 |
01/14/2021 | Translate Bio, Inc. | TBIO | Exercise | Stock Option (right to buy) | 5.6k | $7.39 | $41.7k | | 01/14/2021 |
01/14/2021 | Translate Bio, Inc. | TBIO | Exercise | Stock Option (right to buy) | 1 | $8.34 | $8.3 | | 01/14/2021 |
11/16/2020 | Translate Bio, Inc. | TBIO | Exercise | Stock Option (right to buy) | 53k | $7.39 | $391.7k | | 11/16/2020 |
11/16/2020 | Translate Bio, Inc. | TBIO | Exercise | Stock Option (right to buy) | 3 | $8.34 | $25 | | 11/16/2020 |
04/29/2020 | Atara Biotherapeutics, Inc. | ATRA | Grant | Non-Qualified Stock Option (Right to Buy) | 71.5k | $8.53 | $609.9k | | 04/29/2020 |
03/03/2020 | Translate Bio, Inc. | TBIO | Grant | Stock Option (right to buy) | 525k | $7.66 | $4M | | 03/03/2020 |
06/20/2019 | CHIMERIX INC | CMRX | Grant | Stock Option (Right to Buy) | 21k | $3.37 | $70.8k | | 06/20/2019 |
03/08/2019 | Translate Bio, Inc. | TBIO | Grant | Stock Option (right to buy) | 500k | $7.95 | $4M | | 03/08/2019 |
07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Series C Preferred Stock | 227.3k | $0.00 | $0 | By Ronald Renaud 2014 Irrevocable Family Trust | 07/02/2018 |
07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Common Stock | 40.9k | $0.00 | $0 | By Ronald Renaud 2014 Irrevocable Family Trust | 07/02/2018 |
06/20/2018 | CHIMERIX INC | CMRX | Grant | Stock Option (Right to Buy) | 21k | $4.82 | $101.2k | | 06/20/2018 |
06/14/2018 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $11.14 | $139.2k | | 06/14/2018 |
06/28/2017 | CHIMERIX INC | CMRX | Grant | Stock Option (Right to Buy) | 21k | $5.53 | $116.1k | | 06/28/2017 |
06/15/2017 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $14.37 | $179.6k | | 06/15/2017 |
01/03/2017 | PTC THERAPEUTICS, INC. | PTCT | Grant | Stock Option (Right To Buy) | 12k | $11.23 | $134.8k | | 01/03/2017 |
06/24/2016 | CHIMERIX INC | CMRX | Grant | Stock Option (Right to Buy) | 9k | $3.73 | $33.6k | | 06/24/2016 |
06/16/2016 | Akebia Therapeutics, Inc. | AKBA | Grant | Stock Option (Right to buy) | 12.5k | $8.56 | $107k | | 06/16/2016 |
|